MUC16 Antibody

About the Target

MUC16 (Mucin 16) is the largest known type I transmembrane mucin, originally identified as carbohydrate antigen 125 (CA125), a classic ovarian cancer biomarker. Encoded on chromosome 19p13. 2 and comprising 22,152 amino acids, MUC16 has a massive molecular weight and consists of three main domains: an N-terminal extracellular region rich in O-glycosylation, a large tandem repeat domain containing 16 SEA (sea urchin sperm protein, enterokinase, agrin) modules, and a C-terminal domain with an extracellular segment, a transmembrane region, and a short cytoplasmic tail featuring an NLS, ERM-binding site, and phosphorylated tyrosine. Depending on the literature source, MUC16 may also be discussed as CA125 and Mucin-16.

Reported cellular context includes cell membrane, membrane, and secreted, which can matter when signal is compared across treatments or changing cell states. Following MUC16 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

MUC16 is commonly interpreted in the context of cancer, immunology, and metabolism research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, membrane, and secreted, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, membrane, and secreted across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• context differences tied to immune-cell state, activation, or lineage composition
• responses linked to nutrient status, mitochondrial state, or metabolic rewiring

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MUC16. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MUC16 reflect biology rather than handling. When interpreting MUC16, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MUC16 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.